Market Highlights: CVS Health Corp (CVS) Ends on a Low Note at 61.00

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The price of CVS Health Corp (NYSE: CVS) closed at $61.00 in the last session, down -0.02% from day before closing price of $61.01. In other words, the price has decreased by -$0.02 from its previous closing price. On the day, 6.85 million shares were traded. CVS stock price reached its highest trading level at $61.33 during the session, while it also had its lowest trading level at $60.4.


We take a closer look at CVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.41. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 0.99.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 30, 2024, initiated with a Neutral rating and assigned the stock a target price of $61.

On May 07, 2024, TD Cowen Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $99 to $59.

UBS Downgraded its Buy to Neutral on May 02, 2024, whereas the target price for the stock was revised from $85 to $60.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 02 ’24 when Mahoney Michael F bought 9,181 shares for $54.49 per share. The transaction valued at 500,294 led to the insider holds 9,356 shares of the business.

LUDWIG EDWARD J bought 1,000 shares of CVS for $53,879 on May 02 ’24. The Director now owns 21,630 shares after completing the transaction at $53.88 per share. On Feb 16 ’24, another insider, Shah Prem S, who serves as the EVP and Pres-Pharm, Consumer W of the company, sold 29,473 shares for $76.95 each. As a result, the insider received 2,267,947 and left with 39,765 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVS now has a Market Capitalization of 76590383104 and an Enterprise Value of 145462755328. As of this moment, CVS’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.72, and their Forward P/E ratio for the next fiscal year is 7.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 1.03. Its current Enterprise Value per Revenue stands at 0.404 whereas that against EBITDA is 8.595.

Stock Price History:

The Beta on a monthly basis for CVS is 0.52, which has changed by -0.12356323 over the last 52 weeks, in comparison to a change of 0.2586832 over the same period for the S&P500. Over the past 52 weeks, CVS has reached a high of $83.25, while it has fallen to a 52-week low of $52.77. The 50-Day Moving Average of the stock is -0.57%, while the 200-Day Moving Average is calculated to be -13.17%.

Shares Statistics:

According to the various share statistics, CVS traded on average about 12.48M shares per day over the past 3-months and 10274910 shares per day over the past 10 days. A total of 1.29B shares are outstanding, with a floating share count of 1.25B. Insiders hold about 0.18% of the company’s shares, while institutions hold 81.65% stake in the company. Shares short for CVS as of 1715731200 were 11374710 with a Short Ratio of 1.42, compared to 1713139200 on 17995667. Therefore, it implies a Short% of Shares Outstanding of 11374710 and a Short% of Float of 0.91.

Dividends & Splits

The forward annual dividend rate for CVS is 2.54, which was 2.48 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.040649075The stock’s 5-year Average Dividend Yield is 2.87. The current Payout Ratio is 38.34% for CVS, which recently paid a dividend on 2024-04-19 with an ex-dividend date of 1713484800. Stock splits for the company last occurred on 2005-06-07 when the company split stock in a 2:1 ratio.

Most Popular